Skip to content

Effects of 7-Day Creatine Supplementation on Cognitive Function After High-Intensity Interval Training in Active Young Men

Creatine Monohydrate Supplementation Preserves Cognitive Function in Student Athletes Following High Intensity Interval Training: Implications for Academic Performance

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07534293
Acronym
HIITCRECOG
Enrollment
20
Registered
2026-04-16
Start date
2026-02-07
Completion date
2026-02-14
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Creatine Supplementation, Exercise Ergogenics

Keywords

creatine monohydrate, High Intensity Interval Training, Cognitive, Reaction Time, Executive Function

Brief summary

This study evaluates whether 7-day creatine monohydrate supplementation affects cognitive function after high-intensity interval training (HIIT) in active young men. Twenty participants were assigned to one of four groups: placebo plus exercise, placebo without exercise, creatine 0.1 g/KgBW/day plus exercise, or creatine 0.3 g/KgBW/day plus exercise. Cognitive performance was measured before and after the intervention using visual reaction time, go/no-go visual reaction time, and Trail Making Tests A and B.

Detailed description

This study used a controlled pretest-posttest, four-arm interventional design to examine the effects of short-term creatine monohydrate supplementation on cognitive function after high-intensity interval training (HIIT) in active young men. Twenty participants were allocated into four groups: placebo plus exercise, placebo without exercise, creatine 0.1 g/KgBW/day plus exercise, and creatine 0.3 g/KgBW/day plus exercise. The intervention lasted 7 days. Participants in the exercise groups completed a bodyweight HIIT protocol consisting of two rounds. Round 1 used 40 seconds of work and 20 seconds of rest, and round 2 used 30 seconds of work and 15 seconds of rest, with 30 seconds of rest between rounds. The session included 14 sequential movements and was preceded by a 5-minute warm-up and followed by a 5-minute cool-down. Cognitive performance was assessed before and after the intervention using visual reaction time (VRT), go/no-go visual reaction time (GNGVRT), and Trail Making Test Parts A and B. These measures were selected to capture processing speed, inhibitory control, attention, and executive function. The study was approved by the ethics committee of Universitas Negeri Malang, and written informed consent was obtained from all participants.

Interventions

DRUGCreatine Monohydrate

Creatine monohydrate supplementation at a dose of 0,1 g/KgBW/day for 7 days.

DRUGPlacebo

Placebo supplementation for 7 days

BEHAVIORALHigh Intensity Interval Training

A bodyweight high-intensity interval training program performed in 2 rounds with 40 seconds work and 20 seconds rest in round 1, and 30 seconds work and 15 seconds rest in round 2, with 30 seconds rest between rounds.

Sponsors

Universitas Negeri Malang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Participants were assigned to one of four parallel groups: placebo plus exercise, placebo without exercise, creatine 0.1 g/KgBW/day plus exercise, and creatine 0.3 g/KgBW/day plus exercise.

Eligibility

Sex/Gender
MALE
Age
19 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* Male sport science students aged 19 to 25 years * Physically active and accustomed to high-intensity exercise * Healthy volunteers * Willing to participate and provide written informed consent * Willing to complete the 7-day intervention and cognitive testing procedures

Exclusion criteria

* History of cardiovascular disease * History of kidney disease * Current use of creatine supplements * Current use of pre-workout supplements, steroids, or diuretics * Any musculoskeletal, neurological, or medical condition that could interfere with exercise participation or cognitive testing * Refusal or inability to complete the study procedures

Design outcomes

Primary

MeasureTime frameDescription
Go/No-Go Visual Reaction Time False Alarm ErrorsBaseline and Day 7Number of false alarm (commission) errors recorded during the Go/No-Go Visual Reaction Time test. Lower values indicate better inhibitory control.

Secondary

MeasureTime frameDescription
Go/No-Go Visual Reaction TimeBaseline and Day 7Average response time for correct go trials during the Go/No-Go Visual Reaction Time test, expressed in milliseconds. Lower values indicate faster processing speed.
Trail Making Test Part B Completion TimeBaseline and Day 7Trail Making Test Part B Completion Time
Visual Reaction TimeBaseline and Day 7Simple visual reaction time measured in milliseconds. Lower values indicate faster processing speed.
Trail Making Test Part A Completion TimeBaseline and Day 7Trail Making Test Part A Completion Time

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026